Oregon has legalized the medicinal use of psilocybin. Here is why that's big news for the psychedelic drug industry.
Pure Extracts Technologies Corp. to Commence Trading on the Canadian Securities Exchange (CSE)
Pure Extracts Corp. is an extraction specialist targeting the cannabis, psychedelics and functional mushrooms sectors and will trade on the CSE under the symbol "PULL".
Psychedelics Revolution Front-and-Center As Americans Prepare To Vote
On the eve of the U.S. election, psychedelic drugs are a high-profile election issue.
MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD
This dosing study on LSD will be utilized as MindMed prepares for its Phase 2b clinical trial of LSD for anxiety.
MindMed Has $50 Million In The Bank As It Looks Ahead To NASDAQ Uplisting
With an industry-leading psychedelic drug R&D portfolio, MindMed has plenty of options to leverage its cash-on-hand to a higher share price.
MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines
With MindMed's latest financing, total cash reserves now stand at CAD$50.1 million.
Hapbee to Commence Trading on the TSX Venture Exchange Under the Ticker Symbol "HAPB"
Fitness wearables company, Hapbee Technologies, is going to commence trading October 30th on the TSX Venture Exchange (symbol "HAPB").
Wuhan General Group Updates on University of Pretoria Research Collaboration for Psilocybin Magic Mushroom Clinical Trials
M2Bio Sciences (Wuhan General Group) has finalized an agreement with the University of Pretoria (South Africa) to conduct a psilocybin-based clinical trial.
Champignon Brands Provides Update on Continuous Disclosure Review
Champignon Brands is hopeful that the B.C. Securities Commission is close to revoking its Cease Trade Order for SHRM.
Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development
Field Trip's new psychedelic molecule, FT-104, is showing similar efficacy to psychedelics like psilocybin -- but with shorter duration.
Psychedelic Stocks Offer Great Buying Opportunity In Weak Markets
Markets are tumbling. Where do you want to be positioned AFTER the selloff is over? Psychedelic stocks.
MPV announces CSE’s conditional approval of its transaction with Entheon Biomedical Corp.
Entheon Biomedical has received conditional approval from the CSE to commence public trading.
